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AbstractCell therapy for tissue regeneration requires cells with high self-renewal potential and with the capacity to differentiate into multiple differentiated cell lineages, like embryonic stem cells (ESCs) and adult somatic cells induced to pluripotency (iPSCs) by  genetic  manipulation.   Here  we  report  that  normal  adult  mammalian  bone marrow  contains  cells,  expressing  the  cell  surface  antigen  CD34,  that  naturally express the genes that are characteristic of ESCs and that are required to generate iPSCs.   In  addition,  these  CD34+  cells  spontaneously  express,  without  genetic manipulation,  genes characteristic  of  the three embryonic germ layers ectoderm, mesoderm and endoderm.  In addition to the neural lineage genes we previously reported in these CD34+ cells, we found that they express genes of the mesodermal  cardiac  muscle  lineage  and  of  the  endodermal  pancreatic  lineage  as  well  as intestinal lineage genes.  Thus, these normal cells in the adult spontaneously exhibit the characteristics of embryonic-like stem cells.RésuméLa  régénération  tissulaire  par  thérapie  cellulaire  nécessite  des  cellules  avec  un potentiel  élevé  d'auto-renouvellement  et  une  capacité  de  différenciation  en  de multiples lignages de cellules différenciées,comparable à celle des cellules souches embryonnaires (CSE) et des cellules somatiques induites à la pluripotence (CSIP) par  manipulation  génétique.Nous  rapportons  ici  que  la  moelle  osseuse  de mammifères adultes contient des cellules,exprimant l'antigène de surface CD34,qui expriment naturellement,sans induction, des gènes caractéristiques des CSE et ceux nécessaires  à  la  génération  des  CSIP.De  plus,  ces  cellulesCD34+  expriment spontanément,sans  manipulation  génétique,des  gènes  caratéristiques  des  trois couches embryonnaires ectoderme, mésoderme et endoderme.En plus des gènes du lignage neural  dont  nous avons précédemment  rapporté  l'expression,nous avons observé  que  ces  cellules  CD34+  expriment  des  gènes  du  lignage  mésodermique caractéristiques du myocarde ainsi que des gènes du lignage endodermique propres au développement du pancréas endocrine et  au tube digestif Ainsi  ces  cellules  CD34+  présentes  normalement  chez  l'adulte  expriment spontanément des caractéristiques  comparables à celles des CSE et des CSIP.
IntroductionPluripotency of stem cells is  important for cell  replacement therapy.  Embryonic stem cells (ESCs) exhibit pluripotency [1,2], but because of practical issues, they are problematic for human cell replacement therapy.  This led laboratories to induce pluripotency in  normal adult  somatic  cells  such as skin fibroblasts  (iPSCs)  [3,4].  However, the induction of pluripotency may evoke unknown genetic changes in the cells and cause tumorigenicity [4]  Therefore,  we investigated whether there are natural adult stem cells that express ESC genes and share pluripotency with ESCs.  Indeed, we find that a subpopulation of stem cells from adult bone marrow naturally  expresses an array of ESC genes including Oct-4, Rex-1, Sox-2, Klf-4 and LIN-28 – genes that have been used to induce pluripotent stem cells from adult fibroblasts.Pluripotency means that  the  stem cells  have the potential  to differentiate  into a variety of different lineages.  We examined, in this subset of bone marrow stem cells,  the expression of lineage genes for each of the three embryonic germ layers.  We previously  reported  that  these  bone  marrow  stem  cells  express  an  array  of ectodermal neural genes of both neural progenitors and differentiated neurons and oligodendrocytes  [5}.   Here,  we  find  that  the  same  subset  of  adult  stem  cells expresses  mesodermal  cardiac  lineage  genes  and  endodermal  pancreatic  lineage genes as well as intestinal  genes.  Taken together, the results shown here indicate that  the  expression  of  ESC  genes  does  not  preclude  the  expression  of  terminal differentiated cell genes of each of the three germ layers and that these cells may represent ESC-like cells in the adult.  
Results
Mouse hematopoietic progenitors express embryonic stem cell genes.  Adult bone  marrow  transplants  have  been  performed  for  50  years  for  stem  cell replacement therapy.  This stem cell transplantation gives rise to both myeloid and lymphoid  lineages.   We  asked:  do  these  bone  marrow  stem  cells  have  greater pluripotency and moreover, do they express ESC genes?  We reported earlier that there is a subset of CD34+ cells in  ex vivo bone marrow that expresses ESC genes Oct-4 and Rex-1 and we developed a culture method to grow a pure population of this subset of stem cells [5)]  Here we report that these same ex vivo stem cells and 
in vitro stem cell cultures also express ESC genes Sox-2, Klf-4 and LIN-28 (Fig. 1).  Oct-4, Sox-2 and Klf-4 are ESC genes used by others to induce pluripotency in adult  skin fibroblasts [3,4]  Here, in this subset of CD34+ adult bone marrow stem cells  these genes are expressed naturally without induction.The  expression  of  ESC  genes  by  this  subset  of  CD34+  stem  cells  suggested pluripotency and therefore led us to look at lineage gene expression for each of the three embryonic germ layers, ectoderm, mesoderm and endoderm.  We previously 
reported that these CD34+ cells express both the neural progenitor gene Pax-6 and differentiated  genes  of  neurons  eg.,  neurofilament  and  NeuN  and  of oligodendrocytes  MOSP  and  CNPase  [5].   Here  we  examined  mesodermal  and endodermal lineage genes.
Mouse hematopoietic progenitors express mesodermal lineage genes.  These adult bone marrow stem cells express mesodermal hematopoietic stem cell genes 
(CD34+, Sca-1+, AA4.1+, cKit+, CD45+, GATA-2+, LMO-2+, Flk-2- and Lin-) but not the  differentiated  hematopoietic  lineage  genes  macrophage  F4/80,  endothelial Factor 8, B-cell CD19 and T-cell CD4 and CD8 [5].  Therefore, another mesodermal lineage, the cardiac lineage, was examined.  These bone marrow stem cells express both cardiac  lineage  transcription  factor  MEF-2 as  well  as  differentiated  cardiac genes troponin C and myosin light chain MLC-2 (Fig. 2).  Thus, these CD34+ cells  express mesodermal genes of both hematopoietic and cardiac progenitors. 
Mouse hematopoietic progenitors express endodermal lineage genes. We then moved to examining endodermal lineage gene expression.  Co-expression of CD34 with antigens specific  for the  pancreatic  lineage was first  investigated  ex  vivoby immunocytochemistry  of   bone marrow cells  The first pancreatic gene explored was 
insulin.    Insulin  was  not  detected  ex  vivo in  CD34+  bone  marrow  stem  cells. 
Consequently,  genes expressed in earlier stages of endodermal/pancreatic development 
were investigated.   We found that  about  one third  of  ex vivo CD34+ cells  could  be 
labeled with antibodies specific for three pancreatic endoderm lineage genes Pdx1, Ptf1a 
(Fig. 3) and NGN-3 (not shown). To our knowledge, this is the first report that bone 
marrow  expresses  genes  of  the  endodermal/pancreatic  lineage  without  induction.   In 
addition,  double-labeling  experiments  showed  co-immunolabeling  for  these  three 
proteins in the same cell (not shown).  Furthermore, very few cells, if any, other than 
CD34+ cells were labeled with anti-pancreatic lineage antibodies. 
Also these CD34+ cells cultured in large numbers  in vitro all showed the expression of 
genes from each stage of endodermal/pancreatic development from definitive endoderm 
to  primitive  gut  to  posterior  foregut,  pancreatic  endoderm and  endocrine  precursors. 
Indeed, these cultured CD34+ stem cells all express genes for definitive endoderm Sox17 
and CXCR4, primitive gut HNF1B and HNF4A, posterior foregut Pdx1 and HNF6 and 
pancreatic endoderm PTF1a, NGN3 and NKX2-2.  These genes were expressed both at 
the mRNA level detected by RT-PCR and by semi-quantitative real-time PCR (Fig. 3) 
and at the protein level by immunocytochemistry for Pdx1, Ptf1a, Pax-6 and NGN-3 (Fig. 
3) and Western blot (Fig. 3).  These genes were expressed in CD34+ cultures from the 
three  strains  of  mice  examined:  C3H,  the  C57Bl/6J  transgenic  mouse  that  expressed 
Green Fluorescent Protein, C57Bl/6-Tg(UBC-GFP)30Scha, and the C57Bl/6J transgenic 
mouse that expresses β-galactosidase,  B6.129S7-Gt(ROSA)26Sor/J.  
The endoderm also gives rise to the primitive gut and then to the digestive tract including 
the intestine.  A hallmark of the intestine is the presence of enterocytes localized in the 
mucosa, facing the lumen.  This epithelium has a brush border, a specialized domain of 
the  plasma membrane  composed  of  microvilli.   The  axial-microfilament  bundle  of  a 
microvillus contains a Ca2+-regulated actin binding protein, villin, the best characterized 
protein of the cytoskeleton of intestinal microvilli [6].  It has been shown that the amount 
of villin in mature enterocytes is very significantly higher than in immature intestinal 
(crypt)  cells.   We therefore  investigated  whether  villin  is  also  expressed  in  cultured 
CD34+ cells.  Indeed, we found that villin is expressed at a very high level in these cells  
(Fig. 4). 
Human CD34+ cells express pancreatic lineage and embryonic stem cell genes.  We 
previously examined human CD34+ cells collected from bone marrow and cultured by 
the same method as mouse cells but using human growth factors.  These cells were found 
to  display  the  same  hematopoietic  progenitor  phenotype  as  the  mouse  CD34+ cells. 
Furthermore,  they express  the same neural  genes  as the mouse  (unpublished results). 
Therefore, we investigated the expression of endodermal pancreatic lineage genes in the 
human CD34+ cells in culture.  The human cells were found by immunocytochemistry to 
express  Pdx-1  and  Ptf1a  (Fig.  5).   Interestingly,  the  same  human  CD34+ cells  also 
express embryonic stem cell genes Sox-2, Klf-4 and LIN-28 (Fig. 5).
Discussion
The first question asked in this report was: are there embryonic-like stem cells in the 
adult and the answer is there apparently are such cells since we found that a subset of 
adult bone marrow stem cells expresses both the phenotype of hematopoietic progenitors 
and an array of ESC genes.  The second question was: are these same cells pluripotent 
stem cells.  Indeed, in addition to ESC genes these adult  stem cells express genes of 
ectodermal,  mesodermal  and  endodermal  lineages  suggesting  that  they  may  be 
pluripotent.
Although  these  adult  stem  cells  express  ESC  genes  and  have  the  potential  for 
pluripotency they do not exhibit the unlimited proliferation of ESCs.  The CD34+ cells 
have a limited lifespan since they stop dividing and plateau after 30-40 doublings like 
diploid somatic cells [5)]Accordingly,  these CD34+ cells do not form teratomas when 
injected into a host [5]in sharp contrast to ESCs and iPSCs.
Unlike ESCs and iPSCs these adult stem cells spontaneously express, without induction, 
lineage genes from each of the three embryonic germ layers, ectoderm, mesoderm and 
endoderm.  We previously reported ectodermal neural gene expression by these cells [5]. 
Here, mesodermal cardiac lineage genes MEL-2, an early cardiac stem cell transcription 
factor and differentiated myocyte troponon C and myosin light chain MLC-2 are reported 
to be expressed naturally by a subset of CD34+ cells – genes that have been reported by 
others to be induced in ESCs and iPSCs after in vitro manipulation [7,8,9].
Also this subset of CD34+ bone marrow stem cells spontaneously expresses endodermal 
lineage genes.  Both early and late pancreatic lineage genes are expressed from definitive 
endoderm to primitive gut to posterior foregut and pancreatic endoderm.  In addition they 
express  a  major  structural  gene  of  the  intestinal  epithelial  lineage  –  another  lineage 
derivative of endoderm.
The  potential  of  bone  marrow  cells  to  express  genes  of  the  pancreatic  lineage  was 
previously  suggested  in  a  report  indicating  that  human  marrow-derived  mesodermal 
progenitor cells could generate insulin-secreting islet-like clusters after inoculation into 
human fetal pancreas [10]  Also, human and murine bone marrow mesenchymal stem 
cells  were  shown  to  be  induced  to  a  pancreatic  lineage  after  manipulation  in  vitro 
[10,11,12]   However,  there  are  two  main  differences  between  these  reports  and  our 
present findings.  First, the cells previously studied by these groups are mesenchymal and 
do not express any of the hematopoietic progenitor markers of our CD34+ cells.  Second 
and  more  importantly,  in  the  previous  studies  the  pancreatic  lineage  genes  are  not 
expressed  in vivo by mesenchymal stem cells but are induced only by manipulation in 
culture  as  adherent  cells.   This  is  in  sharp  contrast  with  our  finding  of  a  discrete 
population  of  CD34+  hematopoietic  progenitors,  which  expresses  pancreatic  lineage 
genes ex vivo without any treatment or manipulation [10,11,12,13)]  As discussed above, 
this subset of CD34+ cells expresses markers typical of ESCs.  In this context, it is of 
interest  that  ESCs  also  can  be  differentiated  into  insulin  producing  tissue  [14,15]. 
Furthermore,  iPSCs  from  type-1  diabetes  patients  have  been  converted  into  insulin-
producing  cells  [16]  and  iPSC-derived  pancreatic  beta-like  cells  can  reverse  the 
hyperglycemia in diabetic mouse models [17]
In this report, we have investigated properties of CD34+ cells originating from the bone 
marrow, both ex vivo and in culture.  However, these CD34+ cells eventually leave the 
bone marrow and are found peripherally in the blood circulation.  Although we have not 
investigated the properties of the circulating CD34+ cells, taking into account that these 
peripheral cells are non-adherent, one may speculate that these circulating CD34+ cells 
exhibit the same properties as those taken from the bone marrow that grow non-adherent 
in culture.  The circulating CD34+ cells may thereby provide an autologous source for 
cell replacement by seeding organs, such as the pancreas, intestine or the heart.  In this 
regard,  it  is  of  interest  that  some  investigators  have  reported  that  blood  enriched  in 
CD34+ cells  helps reduce hyperglycemia  in  diabetic  patients  [18].   Accordingly,  one 
should consider the possibility that  in vitro-expanded cultures of CD34+ cells might be 
utilized for cell replacement therapy by injection into the blood circulation or by direct 
inoculation into organs. 
An earlier comprehensive analysis of gene expression by CD34+ cells [19)]apparently 
did not report the ESC genes or embryonic germ layer lineage genes expressed in the 
subset of CD34+ cells investigated in the current study.  It is known that CD34+ cells 
represent a mixed population of cells in bone marrow.  It may be of interest that the genes 
reported here are present only in a subset of CD34+ cells and that subset was selected by 
our culture method.
Taken together,  these  readily  available  bone marrow CD34+ stem cells,  that  express 
embryonic stem cell genes as well as genes of each of the three embryonic germ layers 
(Fig. 6) and that exhibit the capacity to grow in very high numbers, are a potential source 
for cell replacement therapy in multiple tissues and organs.   
  
Materials and Methods
Bone marrow CD34+ stem cell  cultures.  Non-adherent CD34+ hematopoietic stem 
cells were cultured from adult mouse bone marrow with medium containing mouse IL-3, 
IL-6, SCF and β-mercaptoethanol as reported [5].  CD34+ cultures from the three strains 
of  mice  examined:  C3H,  the  C57Bl/6J  transgenic  mouse  that  expressed  Green 
Fluorescent Protein, C57Bl/6-Tg(UBC-GFP)30Scha, and the C57Bl/6J transgenic mouse 
that  expresses  β-galactosidase,   B6.129S7-Gt(ROSA)26Sor/J.   The  University  of 
Maryland School of Medicine OAWA approved these animal studies.  CD34+ stem cells 
were cultured,  by the  same method  as  mouse  cells,  from adult  human  bone marrow 
(Lonza Inc., Walkersville, MD) using human IL-3, IL-6 and SCF.
RT-PCR and semi-quantitative real-time PCR.  CD34+ cell mRNA was analyzed by 
standard RT-PCR and semi-quantitative methods [5].  
Immunocytochemistry.  Cells were treated by standard immunochemistry methods and 
observed by fluorescence microscopy [5)]    
Western blot analysis of protein expression.  Protein expression was determined on 4-
12% polyacrylamide gradient gels (Invitrogen) by standard Western blot methodology 
[5,20,21]  
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Figure legends
1. Embryonic stem cell genes Sox-2, Klf-4 and LIN-28 are expressed in all non-
adherent CD34+ cells cultured from adult bone marrow as reported in M&M.
A. Immunocytochemistry
Cells  were  suspended  in  4%  paraformaldehyde  fixative  for  15  min.  at  4°C, 
washed 3 times in PBS and then deposited on microscope slides by cytospin and 
blocked with PBS containing 0.025% Tween-20 for 30 min. at RT.  Cells were 
incubated for from 2 hours to overnight in primary antibody in Block buffer at 
RT, then washed with PBS 3 times quickly and three 5 min washes.  The primary 
antibodies  used  were:  anti-Sox-2  (Santa  Cruz  sc-20088),  anti-Klf-4  (R&D 
Systems  AF3158)  and  anti-LIN-28  (Santa  Cruz  sc-67266).   The  secondary 
antibodies FITC-anti-rabbit IgG (KPL202-1516) or FITC-anti-goat IgG (KPL 02-
13-06) were added in Block buffer for 2 hrs. at RT and washed as above.  The 
cells were mounted in Vectashield containing the nuclear dye DAPI, the coverslip 
sealed and cells were examined by flurescence microscopy.  All cells with DAPI+ 
nuclei were labeled by each antibody.
B.  Western  blot  analysis  of  the  non-adherent  CD34+  cells  in  culture  with 
antibodies  Sox-2  and  Klf-4.   Protein  expression  was  determined  on  4-12% 
polyacrylamide  gradient  gells  (Invitrogen)  by  standard  methodology  (5). 
Duplicate lanes are shown for each protein.  The MW standard positions (kDa) 
are shown on the left.   The gels were run in triplicate.   Both antibodies were 
strongly reactive.
2. Mouse hematopoietic progenitors express mesodermal lineage cardiac genes. The 
non-adherent  CD34+  cells  in  culture  were  analyzed  by  Western  blot  with 
antibodies  to  the cardiac  lineage  transcription  factor  MEF-2C (Santa  Cruz sd-
13266) and the differentiated cardiac genes troponin C (Santa Cruz sc-7672) and 
myosin  light  chain  MLC-2  (Santa  Cruz  sc-48414).   The  procedure  used  was 
identical to that used in Fig. 1. The MW standard positions (kDa) are shown on 
the left.  The three proteins are expressed at a high level.
3. Mouse hematopoietic progenitors express endodermal lineage genes.  A.  Ex vivo expression of pancreatic lineage genes:  in situ bone marrow cells 
were  removed  onto  microscope  slides  and  treated  immediately  with  4% 
paraformaldehyde  at  4°C.   The  slides  were  processed  as  in  Fig.  1  with 
antibodies to pancreatic lineage genes Pdx-1 (Chemicon AB3243) and Ptf-1a 
(R&D Systems AF6119).  The 2° antibody was TRITC-anti rabbit (KPL 03-
15-06).  A few nucleated cells are immunoreactive to these antibodies.B. Expression of pancreatic lineage genes by the non-adherent CD34+ cells in 
culture.  Cultured CD34+ cells were processed for immunocytochemistry as in 
Fig.  1.  The 1° antibodies  used were anti-Pdx-1 (Chemicon AB3243),  anti-
Ptf1a (R&D Systems AF6119), Anti-CD34 (Pharmingen 553731), anti-Pax-6 
(Santa Cruz sc-11357), anti-Neurogenin-3 (Santa Cruz sc-13793), anti-Actin 
(Chemicon MAB1501R), anti-Sox-2 (Santa Cruz sc-20088), anti-Klf-4 (R&D 
Systems AF3158) and anti-LIN-28 (Santa Cruz sc-67266).  The 2° antibodies 
were TRITC-anti rabbit (KPL 03-15-06) TRITC-anti-mouse (KPL 03-18-06) 
and FITC-anti-mouse (KPL 202-1806).  All cells labeled with the antibodies 
to the pancreatic lineage genes, CD34, neurofilament H and actin.
C. Expression of pancreatic lineage genes in cultured non-adherent CD34+ cells 
by Western blot analysis.  Western blots were carried out as in Fig. 1. The 
MW  standard  positions  (kDa)  are  shown  on  the  left.   The  antibodies  to 
pancreatic lineage genes were strongly reactive.D. Expression of  pancreatic  lineage  gene mRNA by the non-adherent  CD34+ 
cells in culture.  RT-PCR was carried out on cultures of non-adherent CD34+ 
cells.  C3H-1 and C57Bl/6-1 cells had been in culture 6 weeks and C3H-2 and 
C57Bl/6-2 cells for 12 weeks at the time of PCR analysis. CD34+ cells (and 
positive control Min6 cells) were washed with PBS then suspended in lysis 
buffer (RNeasy kit, Quiagen) and RNA was purified on a column following 
the kit protocol.   RNA was quantitated by nanodrop at an absorbance of 260 
nm (one unit  of OD at 260 nm = 40 gm of RNA/ml)  and RNA purity is 
estimated by the absorbance ratio between 260/280 nm.   A sample of RNA 
was loaded on a 1.5% agarose gel in TBE containing BET.  RNA then was 

























cDNA synthesis was performed using SuperScript III Reverse Transcriptase 
(Invitrogen).  Real-time PCR was carried out in a Biometra Thermocycler: 
cDNA denaturation  stage  at  65°C for  5 min.  with  random primers.   PCR 
included 40 cycles of a first step 96°C for 30 sec.; second step 55°C for 30 
sec.; last step 72°C for 40 sec.   Primer products were separated on a 1.0% 
agarose gel-containing BET.   All genes, characteristic of each developmental 
stage, were expressed in the 6-week cultures (except Pax-6 in C57Bl/6) and 
most of them in 12-week cultures.E. Semi-quantitative PCR of pancreatic lineage gene expression in cultures of 
CD34+ cells.   C3H-1, C57Bl/6-1,  C3h-2 and C57Bl/6-2 cell  cultures were 
analyzed by semi-quantitative PCR. For semiquantitative PCR analyses 18S 
ribosomal  RNA was used  as  an  internal  control  and cDNA primers  listed 
above were used.  PCR was carried out in a 96 well plate with IQSyBr Green 
Supermix (BioRad).  PCR was carried out in a MyiQ thermocycler (BioRad). 
cDNA was denatured at 95°C for 8.5 min. then PCR proceeds for 40 cycles: 1 
min  at  95°C,  30  sec.  at  58°C and  1  min.  at  70°C.   The  presence  of  an 
amplification product was verified by the melting curve technique.  Note that 
the highest level of expression is highest in C3H-1 except for Pax-6.
4. Expression of villin in mouse non-adherent CD34+ cells in culture.  Western blot 
analysis was carried out as in Fig.1 with anti-villin antibody (Santa Cruz sc-7672) 
and showed a strong signal. The MW standard position (kDa) is shown on the left.
5. Human hematopoietic progenitors express ESC and pancreatic lineage genes in 
cultures of CD34+ cells.  Human bone marrow cells were cultured by the same 
method as mouse using human growth factors.  The non-adherent CD34+ cells 
displayed  the  same  hematopoietic  progenitor  phenotype  as  the  mouse  CD34+ 
cells. Immunocytochemistry was performed as in Fig. 1 with antibodies to human 
embryonic  stem cell  proteins  Sox-2,  Klf-4 and LIN-28 and pancreatic  lineage 
proteins Pdx-1 and Ptf-1a (the same antibodies that were used for detection of 
mouse proteins).  All cells in the cultures expressed the three ESC proteins and 
both pancreatic lineage proteins.
6. CD34+ stem cell gene expression.  Oct-4, Rex-1 and the neural and hematopoietic 
genes were reported previously (5).  
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